Isomorphic Labs President Jaderberg: All Future Drugs Will Be Designed by AI

Max Jaderberg, President of AI drug discovery company Isomorphic Labs, predicts that all future drugs will be designed by AI, though the timeline for achieving this remains uncertain. Isomorphic Labs, spun out of Google DeepMind, has raised approximately $2.7 billion in cumulative funding and is in talks for a new funding round that could value it at $40 billion or more. The company plans to launch its first clinical trials before the end of the year and is currently still in the preclinical testing stage.